Results 51 to 60 of about 37,311 (268)

Fungal Antimicrobial Resistance: Mechanisms, Drivers, and Global Clinical Burden

open access: yesChemFoodChem, EarlyView.
ABSTRACT Fungal antimicrobial resistance (AMR) is a growing concern for world health caused by an increase in multidrug‐resistant infections, an increase in environmental reservoirs, and the ineffectiveness of current antifungal treatments. Fungal infections continue to be largely excluded from AMR initiatives while causing over 1.6 million deaths ...
Bikash Baral
wiley   +1 more source

Clinical features and risk factors for Sjogren’s syndrome patients suffering from oral candidiasis in Shanxi, China

open access: yesBMC Oral Health
Objectives To investigate the clinical features and risk factors of Sjogren’s Syndrome (SS) patients suffering from oral candidiasis and to provide a foundation for the prevention and treatment of oral candidiasis in SS patients.
Yexing Xing   +3 more
doaj   +1 more source

The prevalence, risk factors and antifungal sensitivity pattern of oral candidiasis in HIV/AIDS patients in Kumba District Hospital, South West Region, Cameroon

open access: yesThe Pan African Medical Journal, 2020
INTRODUCTION: oral candidiasis is one of the most common opportunistic infection in HIV/AIDS patient and it is caused by Candida species. The low absolute CD4+T-lymphocyte count has traditionally been cited as the greatest risk factor for the development
Ngwa Fabrice Ambe   +7 more
doaj   +1 more source

The relation between serum levels of interleukin 10 and interferon-gamma with oral candidiasis in type 2 diabetes mellitus patients

open access: yesBMC Endocrine Disorders, 2022
Background Type 2 Diabetes mellitus (T2DM) is one of the most common endocrine diseases that weakens the immune system. Candida albicans, is part of the natural oral flora and increases in cases of compromised immune systems.
Atefe Halimi   +6 more
doaj   +1 more source

The assessment of therapeutic response of oropharyngeal and oesophageal candidiasis in AIDS using a new scoring system: studies with D0870. [PDF]

open access: yes, 1999
We developed and compared five scoring systems designed to quantitate therapeutic response in cases of oropharyngeal candidiasis. We utilized prospectively collected data on 114 patients treated with several doses of the azole D0870.
Williams, Keith   +7 more
core  

Multi‐Institutional Assessment of Dental Students' Knowledge in Oral Soft Tissue Pathological Entities

open access: yesJournal of Dental Education, EarlyView.
ABSTRACT Objectives This study provides a descriptive, multi‐institutional comparison of dental students' recognition accuracy and management decisions of oral soft tissue pathological entities across four US dental schools. While prior single‐institution studies have evaluated diagnostic ability, this work provides a multi‐institutional comparison to ...
Nicole McKee   +7 more
wiley   +1 more source

Oral Candidiasis Associated with Aging and Salivary Hypofunction in Stomatitis Patients

open access: yesJournal of Fungi
Objectives: Stomatitis is a broad term for oral mucosal inflammation, and oral candidiasis represents one of its common subtypes caused by fungal infection.
Yeon-Hee Lee   +3 more
doaj   +1 more source

FACTORS RELATED TO ORAL CANDIDIASIS IN ELDERLY USERS AND NON-USERS OF REMOVABLE DENTAL PROSTHESES

open access: yesRevista do Instituto de Medicina Tropical de São Paulo, 2016
This study examined the association between oral candidiasis in elderly users and nonusers of prosthesis and its predisposing factors. To this end, we performed a cross-sectional study where saliva samples from 48 patients were collected they used ...
Cyra Maria Pires de Carvalho BIANCHI   +6 more
doaj   +1 more source

Systemic hematogenous dissemination of mouse oral candidiasis is induced by oral mucositis. [PDF]

open access: yes, 2018
The causes of fungemia include immunosuppression and neutropenia stemming from diverse factors as well as the placement of central venous catheters. However, the relationship between fungemia and the oral cavity has not been substantiated. In this study,
Tanaka, Akira   +7 more
core   +1 more source

The safe and effective use of tofacitinib and ustekinumab combination therapy in infantile onset inflammatory bowel disease

open access: yesJPGN Reports, EarlyView.
Abstract Infantile‐onset inflammatory bowel disease (IOIBD) is a rare and severe subset of very‐early‐onset IBD, often associated with immune dysregulation and poor response to conventional therapies. Data regarding the use of Janus kinase inhibitors (JAKI) in this population is limited.
Smridhi Mahajan   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy